BrainsWay Limited (BWAY) - EV/EBITDA Multiple

The price chart for BrainsWay Ltd. (BWAY) demonstrates an EV/EBITDA ratio of 36.95. The business is currently focusing on the global implementation of advanced magnetic stimulation systems and software updates. The firm supplies depression therapy equipment to clinics using a unique coil design. Production is automated via robotics and machine vision, although the development of treatment methods remains the responsibility of leading medical professionals.

EV/EBITDA determines the business value, accounting for net debt relative to operating profit before depreciation and amortization. This algorithm measures the payback period of assets while considering the tax burden and credit obligations. By analyzing the historical EV/EBITDA value, an investor assesses financial stability and the risk of overpaying for a company. For BrainsWay Ltd. (BWAY), this is critical when scaling sales of dTMS systems in clinics treating resistant depression.